Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00468975 | A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients. | PHASE2 | COMPLETED | 42 | — | — | May 1, 2007 | - | Nov 1, 2010 | 6 | Germany, Sweden +1 |
| Name | Type | Description |
|---|---|---|
| PF-610,355 | DRUG | - |
| Salmeterol | DRUG | - |
Inclusion Criteria: * Reversible asthmatic patients (\>15% increase in FEV1 following 200ug salbutamol). * FEV1 greater than or equal to 60% predicted * Stable disease for at least the previous 3 months Exclusion Criteria: * Subjects requiring rescue medication on greater than 2 occasions in the ...